Skip to main content

Day: October 4, 2021

Form 8 (OPD) Stagecoach Group plc

FORM 8 (OPD)   PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER Rules 8.1 and 8.2 of the Takeover Code (the “Code”)   1.        KEY INFORMATION  (a)        Full name of discloser: Stagecoach Group Plc(b)        Owner or controller of interests and short positions disclosed, if different from 1(a):         The naming of nominee or vehicle companies is insufficient. For a trust, the trustee(s), settlor and beneficiaries must be named. N/A(c)        Name of offeror/offeree in relation to whose relevant securities this form relates:         Use a separate form for each offeror/offeree Stagecoach Group Plc(d)        Is the discloser the offeror or the offeree? Offeree(e)        Date position held:         The latest practicable date prior to the disclosure 1 October 2021(f)        In addition to the company in...

Continue reading

Dividend 15 Split Corp. II At-The-Market Equity Program Renewed

TORONTO, Oct. 04, 2021 (GLOBE NEWSWIRE) — Dividend 15 Split Corp. II (the “Company”) announces it has renewed its at-the-market equity program (“ATM Program”) that allows the Company to issue shares of the Company to the public from time to time at the Company’s discretion, effective until June 7, 2023 unless terminated prior to such date by the Company. This ATM Program replaces the prior program established in May 2021 that has terminated. Any Class A Shares or Preferred Shares sold in the ATM Program will be sold through the Toronto Stock Exchange (the “TSX”) or any other marketplace in Canada on which the Class A Shares and Preferred Shares are listed, quoted or otherwise traded at the prevailing market price at the time of sale. Sales of Class A Shares and Preferred Shares through the ATM Program will be made pursuant to the...

Continue reading

AB Science receives FDA authorization to start clinical development program of masitinib in mast cell activation syndrome (MCAS)

PRESS RELEASE AB SCIENCE RECEIVES U.S. FOOD AND DRUG ADMINISTRATION (FDA) AUTHORIZATION TO START CLINICAL DEVELOPMENT PROGRAM OF MASITINIB IN MAST CELL ACTIVATION SYNDROME (MCAS) MCAS IS A NEWLY RECOGNIZED DISORDER, DISTINCT FROM BUT CLOSELY RELATED TO SYSTEMIC MASTOCYTOSIS AND FOR WHICH THERE IS A FAR GREATER PREVELANCE IN THE GENERAL POPULATION Paris, October 04, 2021, 6pm CET AB Science SA (Euronext – FR0010557264 – AB) today announced that its clinical development program of masitinib in adult patients with mast cell activation syndrome (MCAS) has been approved by the U.S. Food and Drug Administration (FDA). The Investigational New Drug (IND) approval letter received from the FDA provides authority to proceed with a Phase II study (AB20006) in patients with severe mast cell activation syndrome. Study AB20006 is titled...

Continue reading

Pfizer and BioNTech Receive CHMP Positive Opinion for COVID-19 Vaccine Booster in the European Union

NEW YORK and MAINZ, Germany, October 4, 2021—Pfizer Inc. (NYSE: PFE, “Pfizer”) and BioNTech SE (Nasdaq: BNTX, “BioNTech”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion on the administration of the companies’ COVID-19 vaccine as a booster dose at least six months after the second dose in individuals 18 years of age and older. The European Commission (EC) will review the CHMP recommendation and is expected to make a final decision on a variation to the Conditional Marketing Authorization in the near future. If the EC grants the variation regarding a booster dose, the decision will be immediately applicable to all 27 EU member states. The positive opinion by the CHMP is based on the clinical trial data shared by the companies, real world evidence...

Continue reading

Alstom Sa: Disclosure of the total number of voting rights and shares forming the share capital as at 30 September 2021

4 October 2021 Disclosure of the total number of voting rights and sharesforming the share capital as at 30 September 2021 Information pursuant to article L. 233-8 II of the Code de commerce and articles 223-16 and 223-11 of the AMF General regulation (Règlement général de l’Autorité des marchés financiers) REGULATED INFORMATIONDate Number of shares with a nominal value of €7 Gross number ofvoting rights30 September 2021 373,391,746 373,391,746    About Alstom      Leading societies to a low carbon future, Alstom develops and markets mobility solutions that provide the sustainable foundations for the future of transportation. Alstom’s product portfolio ranges from high-speed trains, metros, monorail and trams to integrated systems, customised services, infrastructure, signalling and digital mobility...

Continue reading

Postponement of the publication of the half-yearly financial report as at 30 June 2021

Recylex S.A. (Euronext Paris: FR0000120388 – RX) today announced that due to the ongoing debt restructuring processes1, the Company is not in a position to issue its half-yearly financial report as at June 30, 2021. Recylex S.A. will communicate at a later date on the progress of the restructuring process and on the publication of its half-yearly financial report.   *** 1 See press release dated June 2, 2021.   *** Raw materials from urban mines The Recylex Group is a European specialist in the recycling of lead, zinc and polypropylene. For more information about the Recylex Group: www.recylex.eu*** Press & Investor contact: T +33 (0)158 47 29 91 | E info@recylex.eu Recylex S.A. | Registered office: 6 place de la Madeleine | 75008 Paris | France Administrative office: 79 rue Jean-Jacques Rousseau | 92158 Suresnes Cedex |...

Continue reading

Umicore: Transparency notification by Baillie Gifford & Co

Umicore: Transparency notification by Baillie Gifford & CoIn accordance with article 14, § 1 of the law of 2 May 2007 on disclosure of major holdings Baillie Gifford & Co. has recently notified Umicore that it has crossed the statutory threshold of 10% for the total of direct voting rights + equivalent financial instruments.  Summary of the moves:Date on which the threshold was crossed Date of notification Direct voting rights after the transaction Equivalent financial instruments after the transaction Total27 September 2021 29 September 2021 10.01% 0.00% 10.01%The most recent notification contains the following information:Date of notification: 29 September 2021 Date on which the threshold is crossed: 27 September 2021 Threshold of direct voting rights + equivalent financial instruments crossed upwards: 10% Notification...

Continue reading

In partnership with Voltalia, Leroy Merlin is launching a new offer of solar roofs for individuals

Voltalia (Euronext Paris ISIN code: FR0011995588), an international player in renewable energies, announces that it has signed an agreement with Leroy Merlin to launch a turnkey service for the installation of rooftop photovoltaic solar panels for individuals in mainland France. Available on the leroymerlin.fr website, this offer democratizes access to solar energy and allows the greatest number of people to benefit from a simple, reliable and competitive service. Starting October 05, Leroy Merlin customers will be able to take advantage of a solar panel installation service that combines two areas of expertise: that of Leroy Merlin, a specialist in home furnishings and France’s leading DIY network, and that of Voltalia, an expert in renewable energy, particularly solar energy, both in France and internationally. The offer will...

Continue reading

IGE+XAO: Availability of 2021 half year financial report

Toulouse, on 4 October 2021   In accordance with article 221-4 of AMF General Rules, IGE+XAO announces: IGE+XAO Group’s half year financial report regarding the accounts closed out at 30 June 2021 is made available on the website www.ige-xao.com – Investors section – where it can be read or downloaded. It can also be requested directly to the head office of the Company (IGE+XAO – 16 boulevard Déodat de Séverac – CS 90 312 – 31773 Colomiers Cedex, France) or by email: solie@ige-xao.com / Tel.: + 33 5 62 74 36 36 / Fax: + 33 5 62 74 36 37. Within the framework of regulated information, this financial report has been the subject of a full and actual deposit by electronic format to the AMF.   About the IGE+XAO Group For over 35 years, the IGE+XAO Group has been a software publisher designing, producing, selling and supporting a range of Computer...

Continue reading

Dovre’s Suvic has started two new major windmill park construction projects in September

   Dovre Group Plc        Inside information        October 4, 2021 at 7 pm Dovre’s Suvic has started two new major windmill park construction projects in September Suvic Oy continues its growth by starting Nuolivaara and Lappfjärd windmill park projects, which both commenced in the fall. Nuolivaara will include constructing the foundations of 17 windmills for wpd construction Finland Oy. The Lappfjärd windmill park consists of a turn-key construction of the foundations of 31 windmills including 30 kV internal power grid for CPC Finland Oy and Prime Capital AG. Nuolivaara is located in Kemijärvi and Lappfjärd in the city of Kristiinankaupunki. The estimated combined value of the two projects is about 18 million euros. The construction of Nuolivaara is expected to take place in 2021 and Lappfjärd for the most part in H1 of 2022. ”We...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.